Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PD-L1 confers glioblastoma multiforme malignancy via Ras binding and Ras/Erk/EMT activation
Xin Qiu, Dian Hu, Wenqiang Chen, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2018) Vol. 1864, Iss. 5, pp. 1754-1769
Open Access | Times Cited: 134

Showing 26-50 of 134 citing articles:

Targeting the PD-1/PD-L1 pathway in glioblastoma multiforme: Preclinical evidence and clinical interventions
Abolfazl Maghrouni, Maryam Givari, Mohammad Jalili‐Nik, et al.
International Immunopharmacology (2021) Vol. 93, pp. 107403-107403
Closed Access | Times Cited: 40
Emerging principles of brain immunology and immune checkpoint blockade in brain metastases
Jawad Fares, Ilya V. Ulasov, Peter Timashev, et al.
Brain (2021) Vol. 144, Iss. 4, pp. 1046-1066
Open Access | Times Cited: 37
CircRNA VIM silence synergizes with sevoflurane to inhibit immune escape and multiple oncogenic activities of esophageal cancer by simultaneously regulating miR-124/PD-L1 axis
Cao Gao, Yanjie Xu, Lei Qi, et al.
Cell Biology and Toxicology (2021) Vol. 38, Iss. 5, pp. 825-845
Closed Access | Times Cited: 33
Recent Advancement of PD-L1 Detection Technologies and Clinical Applications in the Era of Precision Cancer Therapy
Yuanfeng Zhang, Juanjuan Wu, Chaobin Zhao, et al.
Journal of Cancer (2023) Vol. 14, Iss. 5, pp. 850-873
Open Access | Times Cited: 16
Erianin regulates programmed cell death ligand 1 expression and enhances cytotoxic T lymphocyte activity
Ao Yang, Ming Yue Li, Zhi Hong Zhang, et al.
Journal of Ethnopharmacology (2020) Vol. 273, pp. 113598-113598
Closed Access | Times Cited: 38
T lymphocyte-targeted immune checkpoint modulation in glioma
William Kelly, Amber Giles, Mark R. Gilbert
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 1, pp. e000379-e000379
Open Access | Times Cited: 37
PD-L1 Influences Cell Spreading, Migration and Invasion in Head and Neck Cancer Cells
Jonas Eichberger, Daniela Schulz, Kristian Pscheidl, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8089-8089
Open Access | Times Cited: 36
Combining protein arginine methyltransferase inhibitor and anti-programmed death-ligand-1 inhibits pancreatic cancer progression
Nannan Zheng, Min Zhou, Fang Sun, et al.
World Journal of Gastroenterology (2020) Vol. 26, Iss. 26, pp. 3737-3749
Open Access | Times Cited: 33
PD-L1 Is a Tumor Suppressor in Aggressive Endometrial Cancer Cells and Its Expression Is Regulated by miR-216a and lncRNA MEG3
Daozhi Xu, Peixin Dong, Ying Xiong, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 33
Non-cytomembrane PD-L1: An atypical target for cancer
Honggang Ying, Xiaozhen Zhang, Yi Duan, et al.
Pharmacological Research (2021) Vol. 170, pp. 105741-105741
Open Access | Times Cited: 32
Current understanding of cancer-intrinsic PD-L1: regulation of expression and its protumoral activity
Pedram Yadollahi, Youkyoung Jeon, Wooi Loon Ng, et al.
BMB Reports (2021) Vol. 54, Iss. 1, pp. 12-20
Open Access | Times Cited: 31
Advancements, Challenges, and Future Directions in Tackling Glioblastoma Resistance to Small Kinase Inhibitors
Federica Fabro, Martine L.M. Lamfers, Sieger Leenstra
Cancers (2022) Vol. 14, Iss. 3, pp. 600-600
Open Access | Times Cited: 21
Tetraspanin 7 promotes osteosarcoma cell invasion and metastasis by inducing EMT and activating the FAK-Src-Ras-ERK1/2 signaling pathway
Shijie Shao, Lianhua Piao, Liwei Guo, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 21
PD-L1 upregulation promotes drug-induced pulmonary fibrosis by inhibiting vimentin degradation
Qing Li, Mengsheng Deng, Rentao Wang, et al.
Pharmacological Research (2022) Vol. 187, pp. 106636-106636
Open Access | Times Cited: 21
Recent progress in molecular mechanisms of postoperative recurrence and metastasis of hepatocellular carcinoma
Zhao-Shan Niu, Wenhong Wang, Xiao-Jun Niu
World Journal of Gastroenterology (2022) Vol. 28, Iss. 46, pp. 6433-6477
Open Access | Times Cited: 20
The role of programmed death receptor (PD‐)1/PD‐ligand (L)1 in periodontitis and cancer
Sabine Groeger, Joerg Meyle
Periodontology 2000 (2024) Vol. 96, Iss. 1, pp. 150-169
Open Access | Times Cited: 4
PD-1/PD-L1 axis is involved in the interaction between microglial polarization and glioma
Xipeng Wang, Wei Guo, Ye-Fan Chen, et al.
International Immunopharmacology (2024) Vol. 133, pp. 112074-112074
Closed Access | Times Cited: 4
Discovery of Novel Small-Molecule-Based Potential PD-L1/EGFR Dual Inhibitors with High Druggability for Glioblastoma Immunotherapy
Zichao Yang, Ziqing Liu, Shanhe Wan, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 10, pp. 7995-8019
Closed Access | Times Cited: 4
Immune checkpoint expression and therapeutic implications in IDH1-mutant and wild-type glioblastomas
Avaniyapuram Kannan Murugan, Siddarth Kannan, Ali S. Alzahrani
Current Problems in Cancer (2025) Vol. 55, pp. 101182-101182
Closed Access
Therapeutic Applications of Programmed Death Ligand 1 Inhibitors in Small Cell Lung Cancer
Leena Nabipur, Michael Mouawad, Vishwanath Venketaraman
Biomedicines (2025) Vol. 13, Iss. 2, pp. 401-401
Open Access
Epithelial-mesenchymal transition orchestrates tumor microenvironment: current perceptions and challenges
Yuqi Xie, Xuan Wang, Wenquan Wang, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Biomarkers for the detection of circulating tumor cells
Karol Gostomczyk, Magdalena Drozd, Mohammed Dheyaa Marsool Marsool, et al.
Experimental Cell Research (2025) Vol. 448, Iss. 1, pp. 114555-114555
Closed Access
Cell stemness, epithelial-to-mesenchymal transition, and immunoevasion: Intertwined aspects in cancer metastasis
Simona Romano, Martina Tufano, Paolo D’Arrigo, et al.
Seminars in Cancer Biology (2019) Vol. 60, pp. 181-190
Open Access | Times Cited: 34
Upregulation of PD-L1 expression promotes epithelial-to-mesenchymal transition in sorafenib-resistant hepatocellular carcinoma cells
Guili Xu, Caifang Ni, Hansi Liang, et al.
Gastroenterology report (2020) Vol. 8, Iss. 5, pp. 390-398
Open Access | Times Cited: 30
Prognostic and predictive value of FCER1G in glioma outcomes and response to immunotherapy
Houshi Xu, Qingwei Zhu, Lan Tang, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 25

Scroll to top